Washington Trust’s Bio-Techne TECH Stock Holding History

Washington Trust’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-20	Closed	-$1.17K	–	676
2025 Q1	$1.17K	Hold	20	–	–	﹤0.01%	741
2024 Q4	$1.44K	Hold	20	–	–	﹤0.01%	821
2024 Q3	$1.6K	Hold	20	–	–	﹤0.01%	811
2024 Q2	$1.43K	Buy	+20	New	+$1.47K	﹤0.01%	830

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Washington Trust's TECH Position: Q2 2025 in Review

Washington Trust sold out of Bio-Techne (TECH) in Q2 2025, closing a stake of 20 shares — an estimated $1.17K sold.

Washington Trust first reported a position in TECH in Q2 2024 and held it in 4 quarters. The position peaked at $1.6K in Q3 2024. 554 funds tracked by Wall St. Rank hold TECH as of Q2 2025.

Washington Trust reported no remaining Bio-Techne position as of Q2 2025 after selling out during the quarter.
Washington Trust sold 20 Bio-Techne shares in Q2 2025, an estimated $1.17K.
Washington Trust first reported a position in Bio-Techne in Q2 2024 and held it in 4 quarters.
Washington Trust's Bio-Techne position peaked at $1.6K in Q3 2024.
554 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2025.

Based on Washington Trust's 13F filing for Q2 2025, filed 8 Aug 2025.